Dosimetry and efficacy of a tau PET tracer [18F]MK-6240 in Japanese healthy elderly and patients with Alzheimer ’s disease

ConclusionThe findings supported safety and efficacy of [18F]MK-6240 as a tau PET tracer for Japanese populations. Even though the number of subjects was limited, the radiation dosimetry profiles, pharmacokinetics, and biodistribution of [18F]MK-6240 were consistent with those for non-Japanese populations.Trial registrationJapan Pharmaceutical Information Center ID, JapicCTI-194972.
Source: Annals of Nuclear Medicine - Category: Nuclear Medicine Source Type: research